The alert concerns reports of Prismaflex control units falling out of their upright positions, potentially triggering an ‘Air in Blood’ alarm.
The U.S. FDA has granted emergency use authorizations (EUAs) to Baxter International Inc. for its HF20 Set and ST Set used in continuous renal replacement therapy (CRRT) during the COVID-19 pandemic.